imvanex
bavarian nordic a/s - modificeret vaccinia ankara - bavarian nordic (mva-bn) virus - smallpox vaccine; monkeypox virus - andre virale vacciner, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 og 5. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hæmoragisk feber, ebola - vacciner - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
encepur 1,5 mikrogram/dosis injektionsvæske, suspension, fyldt injektionssprøjte
bavarian nordic a/s - tick-borne encephalitis virus stamme k23 (inaktiveret) - injektionsvæske, suspension, fyldt injektionssprøjte - 1,5 mikrogram/dosis
encepur barn 0,75 mikrog./0,25 ml injektionsvæske, suspension, fyldt injektionssprøjte
bavarian nordic a/s - tick-borne encephalitis virus stamme k23 (inaktiveret) - injektionsvæske, suspension, fyldt injektionssprøjte - 0,75 mikrog./0,25 ml
vivotif 2 mia. bakterier enterokapsler, hårde
bavarian nordic a/s - salmonella typhi stamme ty 21a berna, frysetørret (levende) - enterokapsler, hårde - 2 mia. bakterier
rabipur 2,5 ie/dosis pulver og solvens til injektionsvæske, opløsning, fyldt injektionssprøjte
bavarian nordic a/s - rabiesvirus, stamme flury lep (inaktiveret) - pulver og solvens til injektionsvæske, opløsning, fyldt injektionssprøjte - 2,5 ie/dosis
vaxchora
bavarian nordic a/s - vibrio cholerae, stamme cvd-103-hgr, live - kolera - vacciner - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. denne vaccine bør anvendes i overensstemmelse med officielle anbefalinger.
heplisav b
dynavax gmbh - hepatitis b overflade antigen - hepatitis b - vacciner - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
latanoprost "nordic prime" 50 mikrogram/ml øjendråber, opløsning
nordic prime aps - latanoprost - øjendråber, opløsning - 50 mikrogram/ml
barbarian super 360 vandopløseligt koncentrat
barclay chemicals manufacturing ltd. - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat